SKYE's free cash flow for Q was $-9.38M. For the fiscal year, SKYE's free cash flow was decreased by $-13.97M and operating cash flow was $-3.84M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Operating Cash Flow	$ -13.95M	$ -13.95M	$ 4.57K	$ -6.47M	$ -6.05M	$ -6.03M
Investing Cash Flow	$ 6.60M	$ 6.60M	$ 5.21M	$ -90.87K	$ -7.23K	$ 0.00
Financing Cash Flow	$ 16.44M	$ 16.44M	$ -208.79K	$ 13.08M	$ 6.70M	$ 6.00M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 18.69M	$ 1.25M	$ 8.99M	$ 8.99M	$ 2.47M	$ 1.83M
Income Tax Paid Supplemental Data	$ 3.60K	$ 3.60K	$ 6.74K	$ 1.60K	$ 1.60K	$ 1.60K
Interest Paid Supplemental Data	$ 198.35K	$ 198.35K	$ 333.55K	$ 44.09K	$ 117.46K	$ 371.42K
Issuance Of Capital Stock	$ 4.97M	$ 4.97M	-	$ 6.06M	$ 6.09M	$ 1.92M
Issuance Of Debt	$ 1.12M	$ 1.12M	$ -210.76K	-	$ 566.70K	$ 3.99M
Repayment Of Debt	$ -259.33K	$ -259.33K	$ -891.66K	-	-	$ -3.99M
Free Cash Flow	$ -13.96M	$ -13.96M	$ 4.57K	$ -6.57M	$ -6.06M	$ -6.03M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Skye Bioscience Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing